We showed that the inhibition of STAT3 by Stattic and NSC74859 not only reduced IMQ-induced HIF-1α expression but also significantly repressed glucose utilization in IMQ-treated BCC cells (Fig. 4A). The gene discussed is STAT3; the disease is skin basal cell carcinoma.